腦血氧監測市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球腦血氧監測市場價值為 2.394 億美元，預計到 2034 年將以 6.7% 的複合年成長率成長至 4.623 億美元。這一成長軌跡是由全球外科手術數量的增加和神經系統疾病盛行率的上升所驅動的。隨著全球人口老化和與年齡相關的疾病變得越來越普遍，對有助於確保病患安全（尤其是在高風險臨床環境中）的先進非侵入性監測解決方案的需求日益成長。隨著越來越多的醫療保健提供者重視避免腦血氧去飽和和改善手術效果，腦血氧監測系統已成為現代手術室和重症監護病房的重要組成部分。技術創新和先進監測設備的引入進一步推動了應用，而對患者護理標準的意識提高繼續增強了市場潛力。醫院現在優先考慮整合腦氧監測技術，以防止複雜手術期間的神經損傷，患者也擴大尋求提供這些先進護理解決方案的機構。

老化人口中心血管和神經系統疾病的發生率不斷上升，是該市場最重要的成長動力之一。隨著預期壽命的延長，外科手術的需求也隨之成長，尤其是需要腦功能監測的手術。腦血氧儀可在手術過程中提供即時回饋，使醫護人員能夠快速回應腦部氧合程度的變化。此外，全球手術數量的激增，尤其是涉及心臟和血管系統的手術，也帶來了對這些監測系統的持續需求。手術方案的變化以及醫療專業人員對患者監測技術日益成長的支持，也為市場的擴張增添了動力。

從應用角度來看，腦血氧監測主要用於心臟和血管手術等。僅心臟手術領域，預計複合年成長率將達到6.6%，到2034年將超過2.382億美元。由於使用人工心肺機有腦灌注降低的潛在風險，因此在心臟手術中，腦氧監測尤其重要。隨著外科手術方法的日益先進，確保手術過程中腦部氧合不間斷變得越來越重要，這直接推動了對腦血氧儀的需求。

依年齡層分析，市場分為成人和兒童兩部分。成人市場預計複合年成長率為6.4%，到2034年底市場規模預計將超過2.907億美元。中風、心臟併發症和神經退化性疾病等成人特有疾病的發生率不斷上升，這推動了腦部監測在醫療過程中的應用。此外，用於成人腦部監測的新型血氧儀的法規核准和上市也進一步促進了該領域的成長。

就終端用戶而言，醫院佔據腦血氧監測市場的最大佔有率，佔2024年總收入的48.7%。醫院的主導地位源於其專科護理的可及性以及在手術和重症監護期間使用高階監測系統的優勢。醫院擴大採用腦血氧監測工具，以滿足複雜手術的需求並提高病人安全標準。這些機構不僅擁有必要的基礎設施，還吸引了那些在醫療過程中尋求最高水準護理和技術支援的患者。需要密切監測的醫院和診所就診人數的增加，持續推動著該領域的發展。

從地區來看，美國在該領域仍佔據主導地位。 2023年，美國腦血氧監測市場規模為8,550萬美元，2024年將增加至9,130​​萬美元。預計2025年至2034年期間，美國腦血氧監測市場的複合年成長率將達到5.9%。推動這一強勁成長的因素包括龐大的老齡化人口、先進的醫療基礎設施以及領先醫療器械公司的存在。此外，美國還受益於大量的外科手術、對病人安全的高度重視以及支持採用創新技術的優惠醫療政策。

腦血氧監測產業整合程度適中，前五大廠商佔約55%至60%的市佔率。由於參與者數量有限，市場呈現可控競爭的特徵，占主導地位的公司往往專注於特定的技術領域。許多主要廠商正在投資新產品開發，而其他廠商則透過收購和合作擴大業務範圍。各廠商透過在其設備中提供差異化功能以及瞄準採用率仍在成長的新興市場來定位自身。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 神經系統疾病盛行率不斷上升
    • 腦血氧儀的技術進步
    • 病人安全和腦部去氧飽和意識不斷增強
    • 非侵入性腦監測系統需求不斷成長
  • 產業陷阱與挑戰
    • 測量波動且缺乏準確性
    • 設備成本高
• 成長潛力分析
• 監管格局
• 川普政府關稅
  • 對貿易的影響
    • 貿易量中斷
    • 報復措施
  • 對產業的影響
    • 供給側影響（原料）
      • 主要材料價格波動
      • 供應鏈重組
      • 生產成本影響
    • 需求面影響（售價）
      • 價格傳導至終端市場
      • 市佔率動態
      • 消費者反應模式
  • 受影響的主要公司
  • 策略產業反應
    • 供應鏈重組
    • 定價和產品策略
    • 政策參與
  • 展望與未來考慮
• 技術格局
• 差距分析
• 波特的分析
• PESTEL分析
• 價值鏈分析
• 使用腦血氧儀監測腦缺血的展望

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 心臟手術
• 血管外科
• 其他應用

第6章：市場估計與預測：依年齡層，2021 年至 2034 年

• 主要趨勢
• 成人
• 兒科

第7章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用途

第8章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• CASMED
• Edwards
• GE HealthCare
• HAMAMATSU
• Honeywell
• Masimo
• Medtronic
• Mespere LIFE SCIENCES
• mindray
• NIHON KOHDEN
• NONIN
• sentec
• TERUMO

The Global Cerebral Oximetry Monitoring Market was valued at USD 239.4 million in 2024 and is estimated to grow at a CAGR of 6.7% to reach USD 462.3 million by 2034. This growth trajectory is driven by a rising number of surgical procedures worldwide and an increasing prevalence of neurological conditions. With the global population aging and age-related medical conditions becoming more common, there is a growing demand for advanced non-invasive monitoring solutions that help ensure patient safety, especially in high-risk clinical settings. As more healthcare providers place an emphasis on avoiding cerebral desaturation and improving surgical outcomes, cerebral oximetry monitoring systems have become an essential component of modern operating rooms and intensive care units. Technological innovations and the introduction of sophisticated monitoring devices are further fueling adoption, while greater awareness of patient care standards continues to enhance market potential. Hospitals are now prioritizing the integration of brain oxygen monitoring technologies to prevent neurological damage during complex surgeries, and patients are increasingly seeking out institutions that offer these advanced care solutions.

The increasing frequency of cardiovascular and neurological disorders among the aging population is one of the most significant growth drivers in this market. As life expectancy rises, so does the need for surgical interventions, particularly those requiring brain function monitoring. Cerebral oximeters provide real-time feedback during procedures, allowing medical professionals to respond quickly to changes in brain oxygenation levels. In addition, the surge in global surgeries-especially those involving the heart and vascular system-creates an ongoing demand for these monitoring systems. Changes in surgical protocols and growing support for patient monitoring technologies among healthcare professionals are also adding momentum to this market's expansion.

From an application standpoint, cerebral oximetry monitoring is primarily used in cardiac and vascular surgeries, among other uses. The cardiac surgery segment alone is forecast to grow at a CAGR of 6.6%, reaching over USD 238.2 million by 2034. The need for brain oxygen monitoring is particularly critical during heart operations due to the potential risk of reduced brain perfusion when a heart-lung machine is used. As surgical approaches become more advanced, ensuring uninterrupted brain oxygenation during these procedures becomes more essential, which directly boosts the demand for cerebral oximeters.

When analyzed by age group, the market is divided into adult and pediatric segments. The adult segment is anticipated to experience a CAGR of 6.4%, with a market value expected to surpass USD 290.7 million by the end of 2034. The increasing incidence of adult-specific conditions, including stroke, cardiac complications, and neurodegenerative diseases, is encouraging the use of cerebral monitoring during medical procedures. Additionally, the regulatory clearance and availability of new oximetry devices for adult brain monitoring further contribute to segment growth.

In terms of end users, hospitals hold the largest share of the cerebral oximetry monitoring market, accounting for 48.7% of total revenue in 2024. Their dominance stems from the availability of specialized care and the use of high-end monitoring systems during surgeries and critical care. Hospitals are increasingly adopting cerebral oximetry tools to meet the demands of complex procedures and elevate patient safety standards. These facilities not only have the necessary infrastructure but also attract patients who are seeking the highest levels of care and technological support during medical treatment. The increase in hospital and clinic visits for conditions requiring intensive monitoring continues to propel the segment forward.

Regionally, the United States remains a dominant player in this space. The cerebral oximetry monitoring market in the US was valued at USD 85.5 million in 2023 and rose to USD 91.3 million in 2024. Between 2025 and 2034, the market in the US is expected to grow at a CAGR of 5.9%. Factors contributing to this robust growth include a large aging population, advanced healthcare infrastructure, and the presence of leading medical device companies. The US also benefits from a high volume of surgical procedures, a strong focus on patient safety, and favorable healthcare policies supporting the adoption of innovative technologies.

The cerebral oximetry monitoring industry is moderately consolidated, with the top five players controlling roughly 55% to 60% of the market. With only a limited number of participants, the market shows characteristics of controlled competition, where dominant companies tend to specialize in specific technological niches. Many major players are investing in new product development, while others are expanding their reach through acquisitions and partnerships. Companies are positioning themselves by offering differentiated features in their devices and by targeting emerging markets where adoption rates are still growing.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of neurological disorders
    • 3.2.1.2 Technological advancements in cerebral oximeters
    • 3.2.1.3 Growing awareness regarding patient safety and cerebral desaturation
    • 3.2.1.4 Rising demand for non-invasive brain monitoring systems
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Fluctuation and lack of accuracy in measurement
    • 3.2.2.2 High cost of devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Retaliatory measures
  • 3.5.2 Impact on the Industry
    • 3.5.2.1 Supply-side impact (raw materials)
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (selling price)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Technology landscape
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Value chain analysis
• 3.11 Outlook on monitoring cerebral ischemia using cerebral oximetry

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Cardiac surgery
• 5.3 Vascular surgery
• 5.4 Other applications

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Adult
• 6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 CASMED
• 9.2 Edwards
• 9.3 GE HealthCare
• 9.4 HAMAMATSU
• 9.5 Honeywell
• 9.6 Masimo
• 9.7 Medtronic
• 9.8 Mespere LIFE SCIENCES
• 9.9 mindray
• 9.10 NIHON KOHDEN
• 9.11 NONIN
• 9.12 sentec
• 9.13 TERUMO